Cargando…
SNP algorithms for prediction of efficacy and adverse events of abatacept (ABT)
Autores principales: | Middleton, James E, Matsubara, Tsukasa, Funahashi, Keiko, Koyano, Satoru, Hagiwara, Takafumi, Miura, Takako, Okuda, Kosuke, Nakamura, Takeshi, Iwahashi, Mitsuyoshi, Tsuru, Tomomi, Uchimura, Shoichi, Honjo, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332461/ http://dx.doi.org/10.1186/ar3649 |
Ejemplares similares
-
Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs
por: Takeuchi, Tsutomu, et al.
Publicado: (2014) -
Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan
por: Takeuchi, Tsutomu, et al.
Publicado: (2015) -
Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity
por: Takahashi, Nobunori, et al.
Publicado: (2013) -
Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008) -
Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)